PWSA | USA and FPWR Share Community Update on FDA Patient Listening Session
On June 17, 2021, PWSA | USA and FPWR held a Patient Listening Session with the FDA to share our communityโs experiences related to Prader-Willi syndrome (PWS).ย The purpose of this meeting was to promote dialogue between the FDA and members of the PWS patient community to ensure the FDA has a full understanding of...
Dr. Moris Angulo, MD Opens New Clinic in New York
We are pleased to announce that Dr. Moris Angulo M.D. has opened a new clinic, located in Bablyon, NY, and is accepting patients. Location: Center for Pediatric Specialty Care, 655 Deer Park Avenue, Babylon, NY 11702 To schedule an appointment, call 631-321-2100 ——————————————– Moris A. Angulo, M.D., was born in El Salvador, Central Amรฉrica and...
FPWR and PWSA|USA Request Regulatory Flexibility & Review of NDA for Intranasal Carbetocin
We request the flexibility afforded to other orphan indications when considering whether applications for treatments for PWS should be accepted for review. In a continuation of our joint advocacy efforts supporting the full review of potential drugs for PWS, FPWR and PWSA | USA have submitted a petition letter to the FDA requesting that they...
Harmony Biosciences is seeking people with PWS between the ages of 6 – 65 to enroll in Clinical Trial
Click Here to View and Download Harmony Biosciences’ PWS Trial Infographic